Altium Capital Management LP Pro Mis Neurosciences Inc. Transaction History
Altium Capital Management LP
- $283 Million
- Q3 2024
A detailed history of Altium Capital Management LP transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 581,395 shares of PMN stock, worth $587,208. This represents 0.26% of its overall portfolio holdings.
Number of Shares
581,395Holding current value
$587,208% of portfolio
0.26%Shares
1 transactions
Others Institutions Holding PMN
# of Institutions
20Shares Held
10.1MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT2.79MShares$2.82 Million1.61% of portfolio
-
Armistice Capital, LLC New York, NY2.67MShares$2.7 Million0.06% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.93MShares$1.95 Million0.44% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.59MShares$1.61 Million1.41% of portfolio
-
Heights Capital Management, Inc San Francisco, CA387KShares$390,7620.36% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...